The Medical Letter website uses cookies. By continuing to browse this website you are agreeing to our use of cookies. Find out more      
The Medical Letter on Drugs and Therapeutics
A New Conjugate Meningococcal Vaccine (Menveo)
The full article is available to subscribers Subscriber Login   

The FDA has approved Menveo (Novartis), a new quadrivalent conjugated polysaccharide vaccine, for protection against disease caused by Neisseria meningitidis in people 11-55 years old.

THE DISEASE — About 1000-2000 cases of meningococcal disease occur annually in the US. The case fatality rate has remained higher than 10% for meningitis and up to 40% for meningococcemia. Among survivors, approximately 20% sustain permanent disabilities such as hearing loss, limb amputations and neurological abnormalities. Rates of meningococcal disease are highest in infancy, but a second peak occurs in adolescents and young adults, particularly college freshmen living in dormitories.1

SEROGROUPS — Five major serogroups of N. meningitidis, A, B, C, Y and W-135, cause most invasive disease. Serogroup A is the leading cause of epidemic meningitis worldwide, especially ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: A New Conjugate Meningococcal Vaccine (Menveo)
Article code: 1343b
 Electronic, downloadable article - $25